E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/28/2013 in the Prospect News Bank Loan Daily.

IMS Health launches U.S. and euro term loan repricing to lenders

By Sara Rosenberg

New York, Jan. 28 - IMS Health Inc. held a call on Monday to launch a repricing of its U.S. term loan to Libor plus 275 basis points with a 1% Libor floor from Libor plus 325 bps with a 1.25% Libor floor, according to a market source.

In addition, the company is looking to reprice its euro term loan to Euribor plus 300 bps with a 1.25% floor from Euribor plus 350 bps with a 1.5% floor, the source said.

Bank of America Merrill Lynch is the lead bank on the deal.

IMS is a Parsippany, N.J.-based provider of information, services and technology for the health care industry.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.